The identification of TP53 pathway in CXCL12 fibroblast cells in RA (Table 1) supported our previous results showing that interferons (IFNs) modulate glycosylation and trafficking of major histocompatibility complex (MHC) antigens in RA [2]. The gene discussed is CXCL12; the disease is rheumatoid arthritis.